Anti-CXCL13 antibody can inhibit the formation of gastric lymphoid follicles induced by Helicobacter infection von Yamamoto, K, Nishiumi, S, Yang, L, Klimatcheva, E, Pandina, T, Takahashi, S, Matsui, H, Nakamura, M, Zauderer, M, Yoshida, M, Azuma, T

Volltext

903 Outcomes of well-differentiated papillary peritoneal mesothelioma von Nash, G, Morris, M, Krug, L, Zauderer, M, Rusch, V, Cercek, A

Volltext

COVID-19 in patients with lung cancer von Luo, J., Rizvi, H., Preeshagul, I.R., Egger, J.V., Hoyos, D., Bandlamudi, C., McCarthy, C.G., Falcon, C.J., Schoenfeld, A.J., Arbour, K.C., Chaft, J.E., Daly, R.M., Drilon, A., Eng, J., Iqbal, A., Lai, W.V., Li, B.T., Lito, P., Namakydoust, A., Ng, K., Offin, M., Paik, P.K., Riely, G.J., Rudin, C.M., Yu, H.A., Zauderer, M.G., Donoghue, M.T.A., Łuksza, M., Greenbaum, B.D., Kris, M.G., Hellmann, M.D.

Volltext

Abstract No. 13 Safety and Efficacy of Percutaneous Cryoablation for Primary and Metastatic Intrathoracic, Pleural Based Tumors von Alexander, E., Petre, N., Offin, M., Zauderer, M., Zhao, K., Sotirchos, V., Ziv, E., Solomon, S.

Volltext

P2.14B.05 eVOLVE-Meso: A Global Phase 3 Study of First-Line Volrustomig Plus Chemotherapy in Unresectable Pleural Mesothelioma von Scherpereel, A., Fennell, D.A., Fujimoto, N., Marmarelis, M.E., Tsao, A., Aerts, J., Li, X., Dalvi, T., Jiang, H., Krug, L., Zauderer, M.

Volltext

Developing a cancer-specific geriatric assessment : A feasibility study von HURRIA, Arti, GUPTA, Supriya, KRIS, Mark G, NOY, Ariela, GOMEZ, Jorge, JAKUBOWSKI, Ann, HUDIS, Clifford, KORNBLITH, Alice B, ZAUDERER, Marjorie, ZUCKERMAN, Enid L, COHEN, Harvey J, MUSS, Hyman, RODIN, Miriam, PANAGEAS, Katherine S, HOLLAND, Jimmie C, SALTZ, Leonard

Volltext

MA12.10 Novel Germline Mutations in DNA-Damage Repair and DNA Replication Identified in Patients with Malignant Pleural Mesothelioma (MPM) von Guo, R., Duboff, M., Kris, M., Ladanyi, M., Mandelker, D., Zauderer, M.

Volltext

MA23.05 A Phase II Trial of Nintedanib in Recurrent Malignant Pleural Mesothelioma (MPM) von Wozniak, A., Schneider, B., Kalemkerian, G., Daly, R., Chen, W., Ventimiglia, J., Nagasaka, M., Zauderer, M.

Volltext

P2.06-07 Phase 1 Study of CA-170: First-in-Class Small Molecule Targeting VISTA/PD-L1 in Patients with Malignant Pleural Mesothelioma von Zauderer, M., Brody, J., Marron, T., Pacey, S., Martell, R., Wang, H., Spicer, J.

Volltext

46MO Promoting functional persistence in solid tumor CAR T-cell therapy: Mesothelin-targeted CAR (M28z1XXPD1DNR) with T-cell intrinsic PD1 dominant negative receptor von Adusumilli, P.S., Amador, A.M., Chintala, N., Hou, Z., Offin, M., Pineda, J., Senechal, B., Quach, H.T., Bellis, R., Banerjee, S., Saini, J., Zhu, A., Daly, R.M., Sadelain, M., Rivière, I., Zauderer, M., O'Cearbhaill, R.

Volltext

A phase 1B/2 trial of avelumab and pepinemab as second line for metastatic pancreatic adenocarcinoma von Ruffolo, L.I., Jackson, K.M., Ullman, N.A., Burchard, P.R., Georger, M., Jewell, R., Belt, B.A., Fields, R.C., Mulkerin, D., Evans, E.E., Fisher, T.L., Zauderer, M., Yeh, J., Linehan, D.C.

Volltext

Integrated Biomarker Study of Pepinemab in Combination with Nivolumab or Ipilimumab to Evaluate Immune Cell Composition of TME in Patients with Head and Neck Squamous Cell Carcinom... von Steuer, C., Lesinski, G.B., Evans, E.E., Fisher, T.L., Mallow, C., Olson, B., Pastore, D.R., Leonard, J.E., Smith, E., Zauderer, M., Lowe, M., Kudchadkar, R.R., Wu, C., Patel, M.R., Saba, N.F.

Volltext

P2.06-40 VISTA is Highly Expressed in Malignant Pleural Mesothelioma (MPM) and Independent of PD-L1 Expression von Zauderer, M., Muller, S., Lai, W., Ni, A., Jungbluth, A., Ginsberg, M., Daly, R., Hellmann, M., Ladanyi, M., Sauter, J.

Volltext

MA06.08 A Safety Study of Avelumab plus SBRT in Malignant Mesothelioma von Rimner, A., Yorke, E., Gelblum, D., Shepherd, A., Guttmann, D., Iqbal, A., Daly, R., Offin, M., Fiore, J., Namakydoust, A., Li, H., Mccune, M., Gelb, E., Taunk, N., Von Reibnitz, D., Adusumilli, P., Center, M.S.K., Zauderer, M.

Volltext

MA12.07 gC1qR Expression is Independently Prognostic for Survival Benefit Following Chemotherapy in Mesothelioma von Li, X., Eguchi, T., Aly, R., Chintala, N., Tan, K.S., Messinger, J., Zauderer, M., Ghebrehiwet, B., Adusumilli, P., Peerschke, E.

Volltext

WE-FG-206-06: Dual-Input Tracer Kinetic Modeling and Its Analog Implementation for Dynamic Contrast-Enhanced (DCE-) MRI of Malignant Mesothelioma (MPM) von Lee, S, Rimner, A, Hayes, S, Hunt, M, Deasy, J, Zauderer, M, Rusch, V, Tyagi, N

Volltext

Central Review of Contours and Treatment Plans for Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) – Implementation and Lessons Learned from a Prospective Mult... von Yorke, E.D., Kuo, L., Cho, J., Mak, R.H., Garces, Y., Perez, B.A., Gomez, D.R., Fontenla, S., Czmielewski, C., McKnight, D., Gelb, E., Leung, S., Selesnick, P., Smith, L.M., Turk, C., Kantor, M.E., Zauderer, M., Adusumilli, P., Rusch, V.W., Rimner, A.

Volltext

FP07.05 DREAM3R: Durvalumab With Chemotherapy as First Line Treatment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial von Forde, P., Stockler, M., Kok, P.S., Brown, C., Sun, Z., O'Byrne, K., Yip, S., Anagnostou, V., Cook, A., Lesterhuis, W.J., Hughes, B., Kindler, H., Tsao, A., Zauderer, M., Bricker, A., Oostendorp, M., Marinucci, D., Fitzpatrick, K., Ford, K., Pavlakis, N., Brahmer, J., Ramalingam, S., Nowak, A.

Volltext

1590TiPSafety, tolerability and activity of autologous T-cells with enhanced T-cell receptors specific to NY ESO 1/LAGE 1a (GSK3377794) alone, or in combination with pembrolizumab,... von Reckamp, K L, Akerley, W, Calvo, E, Clarke, J, Edelman, M J, He, K, Moreno, V, Neal, J W, Owonikoko, T K, Patel, J D, Patel, S P, Riess, J W, Sacher, A G, Turcotte, S, Villaruz, L C, Zauderer, M G, Farsaci, B, Skoura, N, Chisamore, M, Johnson, M L

Volltext

Blockade Of The Semaphorin 4d-Plexin B1/B2 Axis Sensitizes Pancreatic Cancer To Immune-Checkpoint Therapy When Combined With Folfirinox von Ruffolo, L.I., Ullman, N.A., Jackson, K.M., Pineda-Solis, K., Georger, M., Jewell, R., Belt, B.A., Galka, E., Schoeniger, L., Hernandez-Alejandro, R., Mallow, C., Evans, E., Fisher, T., Zauderer, M., Linehan, D.C.

Volltext